Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Smith & Nephew Share Price
  4. Smith & Nephew Share Regulatory News
  5. Director Declaration

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Smith & Nephew Information

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,143.50    5.00 (0.44%)
Bid:
1,144.00
Ask:
1,144.50
Spread: 0.50 (0.044%)
Market Cap: £9.66b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director Declaration

4 Nov 2016 13:29

RNS Number : 3963O
Smith & Nephew Plc
04 November 2016
 

4 November 2016

 

Smith & Nephew plc

 

DIRECTOR DECLARATION

 

In accordance with Listing Rule 9.6.14 R the Company announces that Robin Freestone, Non-Executive Director of Smith & Nephew plc, has been appointed as Non-Executive Director of Michael Kors Holdings Ltd with effect from 4 November 2016. Michael Kors Holdings Ltd is listed on the New York Stock Exchange.

 

 

Contact:

 

Susan Swabey

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477317

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNUGGQPGUPQGWC
12345678910
Date   Source Headline
26th Jun 20269:54 amRNSTransaction in Own Shares
26th Jun 20269:52 amRNSHolding(s) in Company
19th Jun 20269:21 amRNSTransaction in Own Shares
17th Jun 20269:03 amRNSHolding(s) in Company
12th Jun 202610:18 amRNSTransaction in Own Shares
11th Jun 20268:42 amRNSHolding(s) in Company
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SYNT
Synthomer
LSE
0.50%
HMEM
Hsbc Msci Em $
LSE
-0.87%
PFD
Premier Foods
LSE
-0.68%
EDL
EDL.L
LSE
0.00%
EXPN
Experian
LSE
1.23%
Trending
GGP
Greatland Resources
LSE
-1.71%
IMM
Immupharma
LSE
3.09%
DFDV
Defi Dev Corp
LSE
158.26%
NTVO
Nativo Resources
LSE
-15.38%
KEFI
Kefi Gold & Copper
LSE
0.19%